» Articles » PMID: 11078484

Ability of 3 Different Meningococcal C Conjugate Vaccines to Induce Immunologic Memory After a Single Dose in UK Toddlers

Overview
Journal J Infect Dis
Date 2000 Nov 15
PMID 11078484
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

To test for immunologic memory after a single dose of meningococcal C conjugate (MCC) vaccine in toddlers, 226 children 12-18 months old were randomized to receive 1 of 3 MCC vaccines, with a C polysaccharide booster 6 months later. The protein conjugate was diphtheria mutant toxoid in 2 vaccines (MCC-CRM(197)) and was tetanus toxoid in the third (MCC-TT). One month after the MCC vaccines, 91%-100% of children had serum bactericidal antibody (SBA) titers > or =8, and 89%-100% had a > or =4-fold increase. Geometric mean titer (GMT) increased from <4 to 215 (95% confidence interval [CI], 166-279). MCC-TT induced higher SBA GMTs (P<.001) and higher proportions with SBA > or =8 (P=.02) than did the MCC-CRM(197) vaccines. By 6 months, GMTs had decreased to 55.1 (95% CI, 40-76), but IgG antibody avidity increased (P<.001). Induction of immunologic memory was confirmed by a GMT of 1977 (range, 1535-2547) after the polysaccharide booster and a further increase in avidity. This evidence justified the use of a single dose in a catch-up immunization program for children 1-18 years old.

Citing Articles

Evaluation of Meningococcal Serogroup C Bactericidal Antibodies after Primary Vaccination: A Multicentre Study, Italy.

Neri A, Fabiani M, Barbui A, Vocale C, Miglietta A, Fazio C Vaccines (Basel). 2022; 10(5).

PMID: 35632534 PMC: 9144765. DOI: 10.3390/vaccines10050778.


Efficacy and Effectiveness of the Meningococcal Conjugate Group A Vaccine MenAfriVac in Preventing Recurrent Meningitis Epidemics in Sub-Saharan Africa.

Viviani S Vaccines (Basel). 2022; 10(4).

PMID: 35455366 PMC: 9027557. DOI: 10.3390/vaccines10040617.


UPDATE ON THE USE OF QUADRIVALENT CONJUGATE MENINGOCOCCAL VACCINES: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Warshawsky T Can Commun Dis Rep. 2019; 39(ACS-1):1-40.

PMID: 31697281 PMC: 6802440. DOI: 10.14745/ccdr.v39i00a01.


Advice for Consideration of Quadrivalent (A, C, Y, W135) Meningococcal Conjugate Vaccine, for use by Provinces and Territories.

Can Commun Dis Rep. 2019; 36(Suppl 2):1-35.

PMID: 31680692 PMC: 6798877. DOI: 10.14745/ccdr.v36i00as2.


Conjugation of Meningococcal Lipooligosaccharides Through Their Non-Reducing Terminus Results in Improved Induction a Protective Immune Response.

Mieszala M, Jennings H, Drab M, Gamian A Arch Immunol Ther Exp (Warsz). 2019; 67(4):237-248.

PMID: 31030218 PMC: 6597602. DOI: 10.1007/s00005-019-00542-9.